Chargement...

Robocath raises a total of €6.4 million ($7.6M) in 2017

6 December 2017

Robocath receives an additional €1.25 million financial contribution from Crédit Agricole Innovations et Territoires (CAIT), an innovation fund managed by Supernova Invest. In line with the company’s growth strategy, the new funding aims to increase the resources available to market the R-OneTM product and launch the development of the next generation of robotics dedicated to the treatment of strokes.

Rouen, December 6, 2017 – Robocath, a company that designs and develops innovative robotic solutions for the treatment of vascular diseases (heart attacks,…

Learn more

Robocath raises €4.7 million ($5.2M) to market its first medical robotic platform, R-One™, in 2018

18 May 2017

Rouen, May 18, 2017 – Robocath, a medical robotics start-up that designs and develops innovative solutions for the treatment of cardiovascular diseases, today announces the conclusion of a new round of fundraising worth €4.7 million ($5.2M). This round was led by M Capital and Normandie Participations. It also involved past investors Go Capital and NCI, who have been supporting the company since 2013. Robocath has already succeeded in raising a total of €1.8 million ($2M) in 2013 and 2015, to…

Learn more
21 May 2019

EuroPCR

Join us booth M53 - Floor 2
#Robocath
Subscribe to our newsletter